February 11, 2022 | |
To, | To, |
BSE Limited, | National Stock Exchange of India Ltd., |
P. J. Towers, | Exchange Plaza, |
Dalal Street, | Bandra Kurla Complex, |
Mumbai - 400001 | Bandra East, Mumbai - 400051 |
(Scrip Code : 532687) | (Scrip Symbol - REPRO) |
Dear Sir/Madam,
Sub: Compliance under Regulation 32(1) of SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015 - Statement of deviation(s) or variation(s)
Please find enclosed herewith the Statement of Deviation(s) or Variation(s) under Regulation 32(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the quarter ended December 31, 2021, duly reviewed by the Audit Committee at its meeting held on February 11, 2022.
We hereby confirm that there has been no deviation or variation in the use of proceeds of funds raised through Preferential Allotment of Equity Shares and Warrants. Hence, NIL reports are being submitted as per the prescribed format.
You are requested to take the above information on record.
Thanking you,
Yours faithfully,
For Repro India Limited
Mukesh Dhruve
Director (DIN: 00081424)
Encl.: As above
_____________________________________________________________________________________
Corporate & Reg. Office: 11th Floor, Sun Paradise Business Plaza, 'B' Wing, Senapati Bapat Marg,
Lower Parel, Mumbai - 400 013, India. Phone: 022-71914000 Fax: 022-71914001
Email: investor@reproindialtd.comWebsite: www.reproindialtd.com
CIN: L22200MH1993PLC071431
Name of listed entity | Repro India Limited | ||||||
Mode of Fund Raising | Public Issues / Rights Issues/ | ||||||
Preferential Issues - Equity | |||||||
/ QIP / Others | |||||||
Date of Raising Funds | October 13, 2021 | ||||||
Amount Raised | Rs. 299,998,080/- | ||||||
Report filed for Quarter ended | December 31, 2021 | ||||||
Monitoring Agency | applicable/ not applicable | ||||||
Monitoring Agency Name, if applicable | NA | ||||||
Is there a Deviation / Variation in use of funds raised | Yes/ No | ||||||
If yes, whether the same is pursuant to change in | NA | ||||||
terms of a contract or objects, which was approved | |||||||
by the shareholders | |||||||
If Yes, Date of shareholder Approval | NA | ||||||
Explanation for the Deviation / Variation | NA | ||||||
Comments of the Audit Committee after review | None | ||||||
Comments of the auditor, if any | NA | ||||||
Objects for which funds have been raised and where | NA | ||||||
there has been a deviation, in the following table | |||||||
Original | Modified | Original | Modified | Funds | Amount of | Remarks, | |
Object | Object, | Allocation | allocation, | Utilized | Deviation/ | if any | |
if any | if any | Variation for | |||||
the quarter | |||||||
according | |||||||
to applicable | |||||||
object | |||||||
- | - | - | - | - | - | - |
- Deviation in the objects or purposes for which the funds have been raised or
- Deviation in the amount of funds actually utilized as against what was originally disclosed or
- Change in terms of a contract referred to in the fund raising document i.e. prospectus, letter of offer, etc.
For Repro India Limited | For Repro India Limited |
Mukesh Dhruve | Kajal Damania |
Chief Financial Officer | Company Secretary & Compliance Officer |
_____________________________________________________________________________________
Corporate & Reg. Office: 11th Floor, Sun Paradise Business Plaza, 'B' Wing, Senapati Bapat Marg,
Lower Parel, Mumbai - 400 013, India. Phone: 022-71914000 Fax: 022-71914001
Email: investor@reproindialtd.comWebsite: www.reproindialtd.com
CIN: L22200MH1993PLC071431
Name of listed entity | Repro India Limited | |||||
Mode of Fund Raising | Public Issues / Rights Issues/ | |||||
Preferential Issues - Warrants | ||||||
/ QIP / Others | ||||||
Date of Raising Funds | October 13, 2021 | |||||
Amount Raised | Rs. 74,999,520/- (25% upfront money) | |||||
Report filed for Quarter ended | December 31, 2021 | |||||
Monitoring Agency | applicable/ not applicable | |||||
Monitoring Agency Name, if applicable | NA | |||||
Is there a Deviation / Variation in use of funds raised | Yes/ No | |||||
If yes, whether the same is pursuant to change in | NA | |||||
terms of a contract or objects, which was approved | ||||||
by the shareholders | ||||||
If Yes, Date of shareholder Approval | NA | |||||
Explanation for the Deviation / Variation | NA | |||||
Comments of the Audit Committee after review | None | |||||
Comments of the auditor, if any | NA | |||||
Objects for which funds have been raised and where | NA | |||||
there has been a deviation, in the following table | ||||||
Original | Modified | Original | Modified | Funds | Amount of | Remarks, |
Object | Object, | Allocation | allocation, | Utilized | Deviation/ | if any |
if any | if any | Variation for | ||||
the quarter | ||||||
according | ||||||
to applicable | ||||||
object | ||||||
- | - | - | - | - | - | - |
- Deviation in the objects or purposes for which the funds have been raised or
- Deviation in the amount of funds actually utilized as against what was originally disclosed or
- Change in terms of a contract referred to in the fund raising document i.e. prospectus, letter of offer, etc.
For Repro India Limited | For Repro India Limited |
Mukesh Dhruve | Kajal Damania |
Chief Financial Officer | Company Secretary & Compliance Officer |
_____________________________________________________________________________________
Corporate & Reg. Office: 11th Floor, Sun Paradise Business Plaza, 'B' Wing, Senapati Bapat Marg,
Lower Parel, Mumbai - 400 013, India. Phone: 022-71914000 Fax: 022-71914001
Email: investor@reproindialtd.comWebsite: www.reproindialtd.com
CIN: L22200MH1993PLC071431
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Repro India Limited published this content on 11 February 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 11 February 2022 12:17:14 UTC.